The Myeloma Minutes

Welcome to The Myeloma Minutes.  We've now moved to a fortnightly release schedule, so you can now hear us every-other Thursday. 

During this episode, Jam & Sally give an in-depth, patient-friendly guide to stem cell mobilisation - the essential step before undergoing an autologous stem cell transplant for multiple myeloma.

📌Key Takeaways:

• Stem cells are collected from your blood - not your bone marrow - thanks to cleve...

Welcome to The Myeloma Minutes.  

During this episode, Jam & Sally talk about a ground-breaking new combination therapy for multiple myeloma available on the NHS from this week.  They highlight how it works, who it’s for, and what patients need to know.

📌Key Takeaways:

• A new 'Trojan horse' drug is now approved on the NHS for first relapse myeloma.

• Treatment is effective, flexible — and may only be needed every few mon...

Welcome to The Myeloma Minutes.  

This episode explores the standard treatment for older or transplant-ineligible patients with myeloma, focusing on the DRD regimen, its side effects, and supportive care options.

📌Key points:

• The DRD combo (Daratumumab, Lenalidomide, Dexamethasone) can keep myeloma controlled for years—even in older patients.

• Steroids are powerful but often reduced or stopped early to improve quality of l...

Welcome to The Myeloma Minutes.  

This episode guides you as a patient or carer through induction therapy for myeloma, focusing on the DVTD regimen, its side effects, supportive treatments, and how to manage them.

💡You'll learn:

• How four powerful drugs work together to fight myeloma — and why you don’t need to suffer through side effects.

• That neuropathy is reasonably common, but catching it early can prevent long-term da...

Welcome to The Myeloma Minutes.  

During this episode, Drs Jam and Sally provide a clear and compassionate guide to first-line treatment for multiple myeloma. 

💡You'll learn:

• About 'induction', 'consolidation' and 'maintenance'—and why they matter.
• Why pathways can often be dictated by age/health.
• ...And that the aim isn’t just survival—it’s living well with myeloma.

This podcast is for informational purposes only ...

Welcome to The Myeloma Minutes.  

This episode explores how bone disease affects people with multiple myeloma and how bisphosphonates like zolendronic acid can help manage pain, prevent fractures, and support treatment.

📌 Three Big Takeaways

• Bone disease isn’t inevitable in myeloma—but needs fast action when it strikes!

• Zolendronic acid can protect your bones and support myeloma treatment—learn how and when it’s used.

• C...

Welcome to The Myeloma Minutes.  

Dr Shaheel Bhuva, a radiologist (and long term colleague of Jam)  joins Drs Jam and Sally to demystify scans in myeloma—explaining what they show, when they're used, and he'll dispel some myths around harmful amounts of radiation! 

3 Key Teakaways:

• Not all bone damage shows up on X-rays—some scans reveal disease before symptoms begin.
• MRI and PET-CT scans can detect myeloma earlier and help ...

Welcome to The Myeloma Minutes.  

During this episode Jam and Sally deep dive into Smouldering Myeloma—explaining what it is, how it’s monitored, the emotional toll of uncertainty, and what patients and carers can expect from evolving research and care approaches.  Conversation points include: 

• Smouldering myeloma is a precancerous condition and it needs careful monitoring to catch changes early.

• Understanding your risk lev...

Welcome to The Myeloma Minutes.  

During this chat with Jam and Sally you'll hear a candid patient perspective on coping with a myeloma diagnosis and the emotional, physical, and practical realities of steroid treatment.

Hit ▶️ and you will learn:

• That “Dexy's Midnight Runners” isn't just a band—it's a nickname for the steroids that turned myeloma treatment into a rollercoaster.

• About Katy's unexpected side effects: From in...

Welcome to The Myeloma Minutes.  

In this episode Jam & Sally explore the role, process, benefits, and realities of clinical trials in myeloma care—what they are, how they work, and what patients and carers need to know.

• Clinical trials offer access to cutting-edge treatments not yet widely available.

• Taking part is always your choice—fully informed, and never pressured.

• You’re not a guinea pig—trials are strictly reg...

Welcome to The Myeloma Minutes.  

In this episode Jam & Sally explore the role of steroids in myeloma.

A cornerstone of myeloma therapy for decades, these powerful drugs have impacted every patient treated for myeloma.

They talk about their benefits, common side effects, and whether newer treatments could reduce the need for them in the future.

You'll hear about the following:

• The important role of steroids as a treatment ...

Welcome to The Myeloma Minutes.  This is a living library of credible information for patients of multiple myeloma and their caregivers.

During this episode, Drs Jam and Sally talk about the roles of different healthcare professionals involved in a multiple myeloma care team within the NHS, helping patients and carers understand who does what and when.

As patients, we hear of Multidisciplinary Teams and MDT meetings, but today you'...

Welcome to The Myeloma Minutes.  This is a living library of credible information for patients of multiple myeloma and their caregivers.

Doctors Jam and Sally treat and speak with patients and caregivers daily.  During this episode they talk about the most common and biggest questions they are asked, including:

• What is Myeloma? Is Multiple Myeloma different?
• Where does this type of cancer start?
• How could is possibly be be...

Dr. Sally Moore

Dr Sally Moore is a Bristol based consultant who specialises in treating patients living with multiple myeloma and other plasma cell disorders. She oversees the delivery of clinical research studies for myeloma patients and has academic interests in how to maximise quality of life for patients and improve outcomes in older, less fit patients.  She frequently contributes to myeloma related educational events for fell...